Clinical trials
Phase 4 Multiple Sclerosis, Relapsing-Remitting trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 2 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 2 |
| EMD Serono | 2 |
| Novartis Pharmaceuticals | 2 |
| Bayer | 1 |
| Berkovich, Regina MD, PhD Inc. | 1 |
| Cornerstone Health Care, PA | 1 |
| Genzyme, a Sanofi Company | 1 |
| Gregory Wu | 1 |
| Johns Hopkins University | 1 |
| Mallinckrodt ARD LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 20 |
| Multiple Sclerosis | 7 |
| Memory Disorders | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.